The IDE will allow the medtech giant to conduct clinical trials at US sites with the robotic surgical system called Ottava.

Johnson & Johnson (J&J) medical devices subsidiary DePuy Synthes has entered into a deal with regenerative medicine company Orthocell to bring regenerative stem cells to all. Core to Orthocell's ...

Johnson & Johnson MedTech has entered into an exclusive commercial distribution agreement with Responsive Arthroscopy, a medical device company specializing in sports soft tissue repair solutions. The ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

J&J inherited the Javelin catheter as part of its $13.1bn acquisition of Shockwave Medical, which completed in June 2024.

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

A shortage of intravenous (IV) saline fluids due to Hurricane Helene is forcing hospitals to defer non-urgent surgeries, and could hurt companies that make medical devices for elective procedures if ...